Press Release

CluePoints Chief Scientific Officer And Pfizer’s Global RBM Program Lead To Speak At #CQOF2021

Join us at #CQOF2021!

As well as hosting a booth at the Clinical Quality Oversight Forum where visitors will be able to learn about our industry-leading Risk-Based Quality Management (RBQM) platform, CluePoints will deliver a co-presentation with Pfizer.

Our Chief Scientific Officer, Steve Young will take to the podium with Pfizer’s Risk-Based Monitoring Program Lead, Lynne Cesario, at 09:30, am on Wednesday, September 29, 2021, to discuss how the use of Risk-Based Quality Management (RBQM) and Centralized Monitoring Enabled Pfizer’s Lightspeed COVID-19 Vaccine Development.

Lynne and Steve will share how and why RBQM principles and Centralized Monitoring were applied to the Pfizer COVID-19 vaccine program and review key takeaways to inform RBQM best practices moving forward.

About the Clinical Quality Oversight Forum

The Clinical Quality Oversight Forum, which will be held in Philadelphia from September 27-29, 2021, presents the community with an opportunity to share best practices for ensuring trial integrity and inspection readiness through effective oversight of internal, vendor and site operations.

It is the first post-pandemic, in-person clinical quality conference.

Portions of the event will be also live-streamed to allow the virtual community to participate without having to travel.

This year’s event will be chaired by David Fryrear, Executive Vice President, Head of Quality Assurance, Astellas Pharma.

The hybrid event takes place from September 27-29 in Philadelphia PA. View the full agenda here.

Want to join us? Register using our unique discount code, cluepoints2021, to save 15%!

Hope to see you there!

The Bold Future of RBQM for CROs
Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding